Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | NegotiumBio and EconSight enter strategic partnershipCapturing AI-driven opportunities in pharma and life science
By: NegotiumBio "We are delighted about working with EconSight," said Christoph Becker, Managing Partner of NegotiumBio. "Not only will this collaboration enhance the support we can provide to our clients in executing their outsourced manufacturing and business strategies, it will also enable them to think more expansively about how they can better position themselves from a capacity planning and technology investment perspective." "Combining NegotiumBio's profound industry expertise with our groundbreaking artificial intelligence solutions creates significant value, as we together tap into new markets and capitalize on emerging opportunities," About NegotiumBio Supporting pharmaceutical and biotechnology innovators programs across all modalities (small and large molecules, cell and gene therapies), we provide unique direct expertise in developing targeted outsourced contract manufacturing strategies, coupled with selecting and managing the right CDMO who can meet our clients' stringent demands for speed, quality and efficiency. Learn more (https://www.negotiumbio.com/ Contact: Dr. Christoph Becker inquiries@negotiumbio.com About EconSight An AI-driven expert in assessing and qualifying technology and industry trends based on next-generation patent analysis, EconSight identifies, analyzes, and evaluates the technological performance of companies, countries, and regions in the most important cutting-edge technologies. Learn more (https://www.econsight.com/ Contact: Kai Gramke info@econsight.ch End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|